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Clinical usage of honey as a 
wound dressing: an update 
Honey is an ancient treatment that is increasingly earning its place in modern 
wound care. Evidence suggests it compares with other dressings in terms of its 
antibacterial properties, ease of use and ability to promote a moist environment 
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ince Molan last covered this topic in 
Journal  of  Wound Care , 1  the re  
have  been a d v a nce s  i n  t h e  
s e l e c t i o n  o f  ho ne y  f o r  u s e  i n  
w o u n d  c a r e ,  b a s e d  o n  i t s  
a n t i b a c t e r i a l  p r o p e r t i e s ,  a n d  i n  
c l i n i c a l  protocols for its use. This paper 
examines wound-healing results achieved with 
honey in the past five years, the extent of its use 
and practical issues relating to its clinical use. 
Use of selected honey 
The potency of honey's antibacterial activity can 
vary up to a hundred-fold.2 Honey's antibacterial 
activity is partly due to the high osmolarity created 
by its sugar content, although this reduces as it is 
diluted by exudate. Honey with no antibacterial 
activity beyond its osmolarity ceases to be effective 
against Staphylococcus aureus when diluted with 
three or four times its volume of exudate.3 However, 
honey produced specifically for wound care can still 
be inhibitory if diluted to 45-60 times its volume. 
Honey's antimicrobial activity is also due to: 
Hydrogen peroxide, which is formed in a 
'slow-release' manner by the glucose oxidase 
added by bees during its production 
Phytochemicals from the nectar of particular 
plant species. 
Both activities can vary from sample to sample. In 
manuka honey (Leptospermum scoparium) and honey 
from some other Leptospermum species the phyto-
chemical activity can be high, with a broad spec-
trum of antimicrobial activity. (This activity, the 
Unique Manuka Factor, is rated as the UMF number 
on honeys on sale.) 
Honey with a median level of hydrogen-peroxide 
activity and manuka honey with a median level of 
phytochemical activity are equally as potent as 
antibacterial agents in vitro,4 although manuka 
honey is  
about twice as effective against enterococci.5 
In wound care the catalase in serum and tissues 
decomposes to some extent the hydrogen peroxide 
produced by many honeys, whereas the 
phytochemical component of Leptospermum honey 
maintains its activity. Also, the glucose oxidase which 
produces the hydrogen peroxide in honey only 
becomes active when honey is diluted, and its 
acidity is neutralised by exudate. In contrast, the 
phytochemical factor in Leptospermum honey is active 
in full-strength honey, giving a more potent 
antibacterial action that diffuses into the depth of 
infected tissues, making it the honey chosen for sale 
for wound care. 
Dressing protocols 
The progressive dilution of honey by exudate, 
together with the absorption of its components into 
the blood stream, means its osmotic and antiseptic 
effects last for only two to three days.6 Other practi-
cal issues that need to be considered when using 
honey as a wound dressing are described below. 
The osmotic effect 
Honey creates a moist environment by drawing ex-
udate to the wound surface, creating a non-adher-
ent interface between the dressing and wound bed. 
Lawrence6 suggested that penetrative osmosis may 
damage wound tissue, but this does not happen as 
the underlying circulation provides a flow of re-
placement fluid.7 However, osmotic withdrawal of 
fluid does prevent maceration of periwound skin. 
Dealing with exudate 
Wound exudate can dilute a honey's antibacterial 
activity, or wash it away, so honey is best soaked 
into a dressing and covered with a secondary dress-
ing, rather than applied directly to the wound. 
Due to its anti-inflammatory action, placing suf-
ficient honey on the wound will decrease the level of 
exudate.8 Until this decrease occurs, frequent 
dressing changes may be needed on exuding wounds if 
the honey is being washed away. A new dressing,9 
comprising honey gelled with sodium alginate, 
forms a rubbery sheet similar to a hydrocolloid. This 
swells into a softer gel as it readily absorbs exudate, 
keeping honey in contact with the wound bed while 
preventing the lateral spread of exudate. A honey 
hydrogel product (L-Mesitran Hydro, Triticum) can 
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 absorb five times its weight of fluid, but contains only 
30% honey before this gets further diluted as exudate 
is absorbed. 
Results observed in clinical practice 
In our clinical experience a variety of chronic, acute, 
infected or heavily colonised wounds that did not 
respond to 'normal management' have been treated 
with honey. Successful healing was achieved in all 
patients except those with arterial insufficiency. 
However, the latter wounds remained free from 
infection and did not deteriorate further. Varicose 
ulcers usually healed within three months, including 
cases where compression could not be used. No 
patients required systemic antibiotics. As a result, 
community nurses in our region use honey as the 
standard treatment for leg ulcers infected or heavily 
colonised with Pseudomonas. 
The most notable results have concerned honey's 
rapid (within 24 hours) cleansing and deodoris-
ing action, particularly on fungating (malignant) 
wounds. Honey also reduces inflammation and exu-
date levels, and may suppress the growth of tumour 
cells, as observed in experimental animals. 10,11 
The following randomised controlled trials of 
honey have demonstrated successful outcomes, when 
compared with other dressing regimens: 
●Honey versus povidone-iodine on central vein 
catheter exit sites of patients on dialysisn 
●Honey versus hydrocolloid on split-thickness skin 
graft donor sites" 
●Honey versus phenytoin on chronic leg ulcers14 
●Honey versus povidone-iodine with 70% ethanol 
washes on severe postoperative wound infections.15 
Table 1 gives examples of case reports where honey 
proved successful after other treatments failed. Many 
used honey dressings we developed — Combine 
(Smith & Nephew) dressing pads impregnated with 
25-35g of UMF12 or UMF13 manuka honey. 
Honey with unspecified antibacterial activity 
The possibility that some honeys may give poor 
results because they have a low level of antibacterial 
activity was demonstrated in a prospective ran-
domised controlled trial comparing honey with 
early tangential excision followed by autologous 
skin grafting for the treatment of burns.16 Honey did 
not provide as good infection control as early tan-
gential excision, although skin grafting was required in 
only 11 of the group treated with honey (n=25). 
However, in other clinical trials, the author 
achieved good infection control with the same 
dressing regimen.17-22 For example, a prospective 
randomised controlled trial17 compared Jambhul 
(Syzygium cumini) honey with silver suiphadiazine in 
two groups of 50 patients. (One sixth of the total burn 
area was full-thickness.) In the honey group the 44 
positive swabs recorded at baseline reduced
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Table I. Examples of honey dressings that have achieved 
successful results after other treatments failed 
Wound Outcome Reference 
Porous non-adherent dressing Pseudomonas eliminated; Robson et al.48 
placed between graft and donor sites healed faster; Robson
49
 
honey dressing better cosmetic results 
36-month-old surgical wound Healed in I month 
in the axilla 
     Cooper et al.
30
 
 Skin lesions infected with Healed within 10 weeks Dunford et al.31 
Pseudomonas, Staphylococcus 
aureus and Enterococcus 
Skin-graft failure of lower leg Healed in 8 weeks: Dunford et al.
28
 
cavity wound; infected with elimination of wound odour 
Pseudomonas, Staphylococcus 
aureus and MRSA: donor-site 
infection 
Hydroxyurea-induced leg ulcer Infection cleared in 14 Natarajan et al.
50
 
infected with MRSA treated days; healed in 21 days 
with UMFI 2 manuka honey 
under DuoDERM (ConvaTec) 
4 x 4cm non-healing traumatic Granulation and Dunford et al28 
wound epithelialisation visible 
within I week; complete 
healing in 6 weeks 
Ulcer from back of knee to 
ankle, infected with 
Streptococcus pyogenes and 
Staphylococcus aureus treated 
with Medihoney 
Elimination of odour; Stewart
32
 
reduction in pain; reduced 
bleeding at dressing 
change; 80% reduction in 
size in 15 weeks 
 
Bilateral leg ulcers, extending 
18cm up from ankle on the 
inner and outer surfaces of an 
88-year-old patient, treated with 
Medihoney 
Healed in 6 weeks Richards
33
 
 Chronic leg ulcers (20 years), Cleaner wound bed; Alcaraz and 
Medihoney compared with infection and exudate Kelly
45
 
Aquacel cleared in 10 days 
 
25-year history of venous 
ulceration and recurrent 
infection treated with  
UMF I0+ manuka honey 
Rapid removal of odour; 
eczema cleared after 10 
days, but infection 
returned under 
compression and 
NA dressing (johnson 
& Johnson) 
Kingsley
51
 
11  
14 cases of gangrene in the 
genitals and perineum. Honey 
was applied directly to the 
wounds, which were covered 
with a honey-soaked compress 
Average debridement time: 
5.2 days; granulation: 9.4 
days; healing: 28.7 days 
Anoukoum et al.
24
 
 
Fournier's gangrene, post Healing in six patients Gurdal et al.25 
surgical debridement 
to four after seven days, compared with 42 positive 
swabs at baseline and 42 after seven days in the 
silver-sulphadiazine group. Use of honey was associ-
ated with a significantly faster rate of healing. Four 
of the honey-treated wounds required grafting com-
pared with 11 treated with silver sulphadiazine. 
Some cases15,23-27 in Table 1 also used honey with 
unspecified antibacterial activity. Good results were 
reported in most of these, but the three cases (out of a 
total of 60) in the trial of Mediprof HoneySoft 
dressing in which there was infection or failure to 
heal may be a reflection of the fact that this honey 
does not have a standardised antibacterial activity. 
Pain and honey dressings 
There have been a few reports of honey causing pain 
when applied to wounds.14,23,28 In one study the 
patient experienced pain for the first 20-30 min-
utes.28 In another case moderate pain occurred for 
15-30 minutes.29 We have observed that pain is ex-
perienced only in very inflamed wounds and disap-
pears once the inflammation has resolved. But there 
are many reports of honey relieving pain.13,15,17,30-33 
The pain experienced does not seem to be asso-
ciated with damage to the wound. But there is 
evidence that honey stimulates nociceptors.34 Inter-
estingly, patients have reported a 'peppery' sensation 
when honey is applied to ulcers.14 It is possible, 
therefore, that in some patients the nerve endings 
are sensitised and thus more responsive to the 
honey's acidity and/or its organic chemicals. 
Acceptance by the medical profession 
In 2000 an answer to a reader's question in Journal of 
Wound Care35 commented that 'honey appears to be 
becoming popular for the management of infected 
wounds'. This has become even more the case, re-
flecting the search for alternatives to antibiotics and 
the increasing awareness of honey's effectiveness. 
Although systematic reviews have concluded that 
there is a low level of evidence to support the use of 
honey on chronic wounds,36-38 they have not 
acknowledged that in many published case reports it 
was only used after standard treatments failed. 
(Most of the randomised controlled trials on honey 
have been on acute wounds.) 
Following increasing evidence from 
laboratory-based research of honey's antimicrobial 
properties and from clinical experience of its 
ability to promote healing, editorial comments in 
medical journals are now changing from being 
disparaging39-41 to accepting.35,42,43 
Honeys produced specifically for 
wound care 
There are over 500 reports of case studies and clinical 
trials where honey intended as a food product has 
been used as a wound dressing, and none have 
Retrospective review of 50 Good response  
cases of lactational breast 
abscesses incised, drained and 
packed daily with honey- 
soaked ribbon gauze 
1 6  acute traumatic, 23 two wounds did not 
complicated surgical and heal but did not worsen. 
21 chronic non-responding Others healed in a mean 
wounds treated with time of 3 weeks (range: 
HoneySoft (Mediprof) 1-28 weeks) 
reported any adverse effects.8 However, clinicians 
are reluctant to use non-sterile products on open 
wounds, and it is unlikely the bacterial content of 
raw honey would meet regulatory requirements for 
wound-management products. Although raw honey 
does not contain disease-causing vegetative bacteria 
(unless recently contaminated), it can contain viable 
bacterial spores, including Clostridium species44 
Several commercially available honey items pro-
duced specifically for wound care have been 
approved by the regulatory authorities: 
● Australia, Canada and EU member states — a 
honey ointment (L-Mesitran, Triticum) comprises 
honey and Medilan, sunflower oil, cod liver oil, aloe 
vera, calendula, vitamins A, C and E and zinc 
oxide; L-Mesitran Hydro (Triticum), a hydrogel 
dressing that contains 30% honey and is also 
available as an island dressing (L-Mesitran Border) 
or incorporated into an open-weave polyester net 
(L-Mesitran Net). The Triticum products are made 
from honey of unspecified origin and antibacterial 
activity 
● Australia and all EU member states — Medihoney 
Antibacterial Wound Gel, Medihoney Antibacterial 
Honey Barrier (Medihoney, Australia) and (in 
Australia) Woundcare 18+ (Comvita Medical, New 
Zealand). These honeys are harvested from Leptosper-
mum species, and their standardised antibacterial 
activity stems from the unidentified phytochemical 
antibacterial component derived from Leptosper-
mum. Medihoney is funded for use in hospitals in 
Queensland and New South Wales, Australia 
● All EU member states — Activon Tulle (Advancis) a 
triple layer of low-adherent knitted viscose primary 
dressing BP Type 1 impregnated with honey, and 
Algivon dressing (Advancis), a honey-impregnated 
mechanically bonded calcium alginate (M type) fibre 
dressing. Both are made from Leptospermum honey 
with standardised antibacterial activity. Activon 
Tulle is available on the Drug Tariff in the UK 
Table I (continued). Examples of honey dressings that have 
achieved successful results after other treatments failed 
Wound Outcome Reference 
Efem26 
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Skin excoriation due to Rapid epithelialisation Aminu et al.
27 
ostomy bag leakage 
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for use of granulated sugar 
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2000; 135:12, 1414-1417. 
12 Mutjaba Quadri, K.H. 
Topical honey versus 
standard povidone-iodine 
in the prevention of 
catheter-related sepsis.) Am 
Soc Nephrol 1998; 9: 
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 ● Australia, New Zealand and all EU member states 
--Apinate dressing (Comvita Medical, New Zealand), 
a honey-impregnated mechanically bonded calcium 
alginate (M type) fibre dressing made from Leptosper-
mum honey with standardised antibacterial activity a 
● All EU member states — HoneySoft dressings 
(Mediprof) are pads of polyethylenevinylacetate 
fibre impregnated with honey of unspecified origin 
and antibacterial activity. HoneySoft is reimbursed 
in the Netherlands, in Belgium for trauma patients, 
in burn centres in England that have their own 
budgets, and in Greece. 
The use of honey-impregnated dressings, honey 
ointments and honey gel dressings have overcome 
comments that honey is messy to use and difficult 
to keep in place.6,45,46 
Conclusion 
In 1999 an editorial in Advances in Wound Care com-
mented that there is a 'tremendous opportunity to 
re-examine old treatments and apply them in the 
current environment'.47 Honey, the most ancient of 
Box I . Key issues for practice 
Potency of honeys' antibacterial activity can be variable 
— use honey with standardised antibacterial activity 
Only use products licensed for wound care as they 
have been finely filtered and sterilised by 
gamma-irradiation to kill spores 
Ensure sufficient honey remains In contact with the 
wound bed by using absorbent dressings impregnated 
with honey, or honey gel dressings. Fill any cavities with 
honey 
Ensure the dressings cover any areas of inflammation 
surrounding the wound. Due to honey's high osmolarity, 
there is no risk of skin maceration 
Change dressings often enough to prevent the 
exudate washing the honey out of the dressing 
wound treatments, is taking its in place in modern 
wound care. Like modern wound dressings, it is easy 
to apply, painless and comfortable, harmless to tis-
sues, creates a moist healing environment, is antibac-
terial and stimulates healing and epithelialisation.8 
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